First-line immune therapy - Implications for pathologists Editorial Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • Carcinoma, Non-Small-Cell Lung
  • Drug Therapy
  • Lung Neoplasms

publication date

  • August 2016

Research

keywords

  • Editorial

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.5858/arpa.2016-0904-ED

PubMed ID

  • 27472228

Additional Document Info

start page

  • 739

end page

  • 40

volume

  • 140

number

  • 8